Drug Trial Radar · NCT07025824
Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation
Last checked: Nov 20, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Jan 21, 2026
Primary completion
Sep 2029
Study completion Sep 2029
Sponsor
- Lead sponsor
- Technische Universität DresdenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- medac GmbH
- First posted
- Jun 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to compare the effectiveness and tolerability of two conditioning chemotherapies prior to allogeneic stem cell transplantation. The following will also be investigated: * Survival * Remission and Relapse rate * Engraftment or graft failure * Graft versus Host Disease (GvHD)
Conditions
- AML - Acute Myeloid Leukemia
- MDS (Myelodysplastic Syndrome)
Interventions
Treosulfan (Treo)Drug
10 g/m2 intravenous
Melphalan (Mel)Drug
140 mg/m2 intravenous
Fludarabine (Flud)Drug
30 mg/m2 intravenous
Primary outcomes
What the sponsor says the trial is designed to measure.
- overall survival (OS)Time frame: 2 years after randomization
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Universitätsklinikum Aachen, Medizinische Klinik IV
Aachen, Germany · Recruiting
Klinikum Augsburg, Medizinische Klinik II
Augsburg, Germany · Recruiting
Helios Klinikum Berlin Buch, Klinik für Onkologie und Palliativmedizin
Berlin, Germany · Recruiting
Klinikum Chemnitz gGmbH; Klinik für Innere Medizin III
Chemnitz, Germany · Recruiting
Universitätsklinikum Köln, Klinik I für Innere Medizin
Cologne, Germany · Recruiting
Medizinische Fakultät der TU Dresden, Medizinische Klinik und Poliklinik I
Dresden, Germany · Recruiting
Universitätsklinikum Frankfurt, Medizinische Klinik II
Frankfurt am Main, Germany · Recruiting
Universitätsklinikum Greifswald, Klinik und Poliklinik für Innere Medizin C
Greifswald, Germany · Recruiting
Universitätsmedizin Halle (Saale), Klinik für Innere Medizin IV
Halle, Germany · Recruiting
Universitätsklinikum Jena, Klinik für Innere Medizin II
Jena, Germany · Recruiting
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Innere Medizin II
Kiel, Germany · Recruiting
Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie
Leipzig, Germany · Recruiting
Klinikum der Johannes Gutenberg Universität, III. Medizinische Klinik und Poliklinik
Mainz, Germany · Not yet recruiting
Universitätsklinikum Münster, Medizinische Klinik A, KMT-Zentrum
Münster, Germany · Recruiting
Klinikum Nürnberg, Campus Nord, Klinik für Innere Medizin 5
Nuremberg, Germany · Recruiting
Universitätsklinik Rostock, Klinik und Poliklinik für Innere Medizin, Abt. für Hämatologie/Onkologie
Rostock, Germany · Recruiting
Robert-Bosch-Krankenhaus, Hämatologie, Onkologie und Palliativmedizin
Stuttgart, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.